Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study.
Hyang Nina KimRobin M NanceJessica S Williams-NguyenJ A Chris DelaneyHeidi M CraneEdward R CachayJeffrey MartinW Christopher MathewsGeetanjali ChanderRicardo FrancoChristopher B HurtElvin H GengBenigno RodriguezRichard D MooreMichael S SaagMari M Kitahatanull nullPublished in: Open forum infectious diseases (2019)
Our study represents a large multicenter examination of DAA therapy in HIV/HCV-coinfected patients. The broad treatment success we observed across this diverse group of patients with significant comorbid conditions is highly affirming and argues for widespread implementation of DAA therapy.
Keyphrases
- hepatitis c virus
- human immunodeficiency virus
- antiretroviral therapy
- healthcare
- end stage renal disease
- hiv positive
- hiv infected
- newly diagnosed
- chronic kidney disease
- hiv aids
- randomized controlled trial
- quality improvement
- ejection fraction
- primary care
- prognostic factors
- mesenchymal stem cells
- stem cells
- hiv testing
- patient reported outcomes
- cross sectional
- clinical practice
- bone marrow
- double blind
- pain management
- clinical trial
- patient reported
- chronic pain
- south africa